Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Induction Therapy for Living Donor Renal Transplantation
NCT01095172Phase 4Unknown
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Nov 2010
- Primary completion
- Oct 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of rituximab in kidney transplant rejection (2 arms), sponsored by Guy's and St Thomas' NHS Foundation Trust. Primary endpoint: Estimated Glomerular Filtration Rate at 1 year. Status: unknown.
02
Drugs
rituximab
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT01095172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01095172.